Qiagen eBook lead image

Unlocking the Cancer Code

In this eBook, sponsored by Qiagen, we explore the opportunities and challenges of precision oncology and how molecular profiling is fundamental not only to inform on tumor diagnosis and prognosis, but also to drive therapeutic decisions in routine clinical care.
Bio-Rad Lead Image

Promising COVID-19 Immunotherapy Targets CCR5

In this Clinical OMICs webinar, sponsored by Bio-Rad, IncellDx presents an overview of CCR5 antagonists and the ddPCR data that enabled validation of their hypothesis to move 4 CCR5 inhibitors into trials for treatment of COVID-19.

Rethinking Rx-Dx Codevelopment

Codevelopment is an intermittent and uncertain process. Adopting an agnostic approach to the challenges associated with platform and method selection provide added degrees of freedom for strategic development and selection of the most appropriate clinical trial assay.
Medical concept of cancer. 3d illustration of T cells or cancer cells.

Cell and Gene Therapy Clinical Trials

The promise of cell and gene therapies to solve some of our most challenging conditions, from rare diseases to cancers, has led this field to remain on the forefront of innovation. Advances in innovative technologies coupled with deeper scientific knowledge in cellular and molecular biology spurred a new era of growth in these advanced therapies.

Predicting Breast Cancer Outcomes Using AI Models and Federated Learning

In this Clinical OMICs webinar, sponsored by Owkin, a distinguished panel of breast cancer experts and machine learning researchers, including world-renowned expert Dr. Fabrice André, will explore how clinicians and data scientists can collaborate to accelerate research through the application of novel computational and federated learning techniques.
Chromosomes at Work

Optical Mapping in Rare Genetic Disease Diagnosis

Sponsor: Bionano Genomics
Conceptual Circuit Intelligence

Mainstreaming Precision Oncology

Sponsored content brought to you by   What if every patient’s oncologist or lab testing personnel had access to an online digital encyclopedia of cancer mutations,...

How Multi-Omics Profiling Can Redefine Precision Health and Medicine

Coupling relatively routine datasets such as genomes and transcriptomes with newer types produces an “integrative Personal Omics Profile".

Interpreting NGS Tests for Inherited Disorders

Today genetic innovation is advancing at breakneck pace. Despite incredible advances in sequencing technology, most notable being next-generation sequencing (NGS), genetic has only recently become a clinical application. The challenge is no longer how to sequence DNA, but how to interpret a patient’s genetic variation in a meaningful and actionable way. In this eBook Qiagen looks at three trends that will change how NGS tests for inherited disorders are analyzed and interpreted in the future.
Scroll Up